CatalystWireBeta

2026 Annual General Meeting notification

In brief · summary, not quotable

Oxford Biomedica notifies shareholders of 2026 Annual General Meeting scheduled for 7 May 2026.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes

Oxford, UK - 30 March 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, gives notice that the Notice of Annual General Meeting ("AGM") together with a copy of the 2025 Annual report and accounts are being mailed to shareholders today. These documents are also available on the "Investors" section of the Group's website at www.oxb.com.

In accordance with UK Listing rule 6.4.1R, a copy of the Notice of AGM has been submitted to the Financial Conduct Authority for publication through the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Company intends to hold its AGM on 7 May 2026 at its offices at Windrush Court, Transport Way, Oxford OX4 6LT, commencing at 3:00 p.m.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note